Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Examining the Usage of Dopamine Blockers in OCD Patients

This study has been completed.
Information provided by:
Sheba Medical Center Identifier:
First received: July 4, 2007
Last updated: January 31, 2010
Last verified: January 2010

We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency of usage, compare the course of the disease between those who receive and those who do not receive Dopamine blockers, and efficacy of the treatment.

The study will be done in two stages: 1. Collecting information the usage of Dopamine blockers from 150 OCD patients' files. 2. interviewing 60-70 patients to see the difference those who receive and those who do not receive Dopamine blockers in their current severity of disease.

Obsessive Compulsive Disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Examining the Usage of Dopamine Blockers in OCD Patients

Resource links provided by NLM:

Further study details as provided by Sheba Medical Center:

Enrollment: 63
Study Start Date: November 2007
Study Completion Date: July 2009
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Outpatient and Inpatients

Inclusion Criteria:

  • Patients over 18 years of age
  • DSM-IV diagnosis of OCD
  • Ability to understand patient information sheet, and consent to participate

Exclusion Criteria:

  • Current or past Psychotic or Bipolar disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00496925

Chaim Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Joseph Zohar, MD Chaim Sheba Medical Center
  More Information

Responsible Party: Prof. Joseph Zohar, Chaim Sheba Medical Center Identifier: NCT00496925     History of Changes
Other Study ID Numbers: SHEBA- 07-4651-JZ-CTIL
Study First Received: July 4, 2007
Last Updated: January 31, 2010

Additional relevant MeSH terms:
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Compulsive Behavior
Personality Disorders
Mental Disorders
Anxiety Disorders
Impulsive Behavior
Dopamine Antagonists
Cardiotonic Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Protective Agents processed this record on April 28, 2017